Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Interest & Investment Income (2017 - 2025)

Puma Biotechnology's Interest & Investment Income history spans 9 years, with the latest figure at $977000.0 for Q4 2025.

  • For Q4 2025, Interest & Investment Income fell 20.31% year-over-year to $977000.0; the TTM value through Dec 2025 reached $4.1 million, down 13.67%, while the annual FY2025 figure was $4.1 million, 13.67% down from the prior year.
  • Interest & Investment Income reached $977000.0 in Q4 2025 per PBYI's latest filing, down from $1.0 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $1.3 million in Q3 2024 to a low of $13000.0 in Q1 2021.
  • Average Interest & Investment Income over 5 years is $619000.0, with a median of $674500.0 recorded in 2023.
  • Peak YoY movement for Interest & Investment Income: plummeted 96.63% in 2021, then surged 4030.77% in 2023.
  • A 5-year view of Interest & Investment Income shows it stood at $13000.0 in 2021, then skyrocketed by 3892.31% to $519000.0 in 2022, then skyrocketed by 38.54% to $719000.0 in 2023, then surged by 70.51% to $1.2 million in 2024, then decreased by 20.31% to $977000.0 in 2025.
  • Per Business Quant, the three most recent readings for PBYI's Interest & Investment Income are $977000.0 (Q4 2025), $1.0 million (Q3 2025), and $956000.0 (Q2 2025).